Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Price 'Not Aware' Of Stock Choices During HIP Act Consideration, He Tells Senators

Executive Summary

HHS Secretary Nominee Rep. Tom Price, R-Ga., told members of a key Senate health panel that he was "not aware" of purchases his broker made of stocks in health-care companies including Zimmer Biomet Holdings Inc., shortly after introducing The HIP Act to delay a CMS orthopedics bundled payment program. The appointee also signaled his intentions 'not to pull the rug out' on millions of Americans' insurance coverage in any Affordable Care Act replacement plan he works on.

You may also be interested in...

Price Wins Confirmation As US Health Secretary; Verma On Deck For CMS Hearing

Senators voted 52 to 47 to confirm Rep. Tom Price, R-Ga., as Health and Human Services secretary, where he will be a key leader implementing reversals to the Affordable Care Act. Meanwhile, Trump’s pick to lead the Medicare agency, Seema Verma, faces a confirmation hearing in the Senate Feb. 16.

HHS Nominee Price's Stock Picks To Surface At Confirmation Hearings

Questions about US Health and Human Services Secretary nominee Tom Price's investments over the last year – including in Zimmer Biomet – and overlapping legislation he has introduced are likely to be raised at confirmation hearing before the Senate HELP Committee this week. However, Zimmer Biomet and other device firms have been trying to profit from the business models that Price opposes.

Industry Backs Price To Head HHS, Believes ACA Repeal Will Result In No Coverage Gaps

Industry representatives – including the head of the Access to Medical Imaging Coalition and a former chief operating officer at Boston Scientific – remain unconcerned about expected major drops in health insurance coverage if a Republican-controlled Congress and HHS secretary appointee Tom Price repeal Obamacare this year, saying that proposed Republican replacement plans will fill the gap. Current HHS Secretary Sylvia Burwell disagrees, and laid out the reasons why in a Jan. 9 speech.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts